세계의 OTC 국소 의약품 시장 보고서(2025년)
Over The Counter (OTC) Topical Drugs Global Market Report 2025
상품코드 : 1769694
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,448,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,320,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,193,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

OTC 국소 의약품 시장은 향후 몇 년 동안 강력한 성장을 보일 것으로 예상됩니다. 이러한 성장 전망에 기여하는 요인은 온라인 쇼핑 플랫폼의 사용 확대, 경미한 상처 및 감염의 발생률 증가, 허브 및 식물 기반 국소 치료제에 대한 관심 증가, OTC 통증 관리 솔루션에 대한 수요 급증, 디지털 건강 기술의 채택 증가 등입니다. 예측 기간에 예상되는 주요 동향으로는 의약품 전달 기술의 혁신, 제품 개발에 AI 적용, 기술에 의한 맞춤형 스킨케어 솔루션, 피부과학의 발전, 제품 포장 및 적용 방법의 개선 등이 있습니다.

피부암 발병률의 증가는 OTC 국소 의약품 시장의 성장을 촉진할 것으로 예상됩니다. 비정상적인 피부 세포의 통제되지 않은 증식이 특징인 피부암은 일반적으로 태양이나 태닝 침대에서 나오는 자외선(UV)에 의해 발생합니다. 자외선에 과도하게 노출되면 피부 세포의 DNA가 손상되어 피부암 발병 위험이 높아집니다. OTC 국소 약물은 치료 중 증상 및 피부 자극을 관리하는 데 보조적인 역할을 하며, 처방된 치료법을 보완하는 접근성이 뛰어난 완화 옵션을 제공합니다. 이러한 제품은 환부 진정 및 피부 회복을 촉진하여 환자의 편안함을 향상시킵니다. 예를 들어, 호주 정부 기관인 Cancer Australia에 따르면 2023년 피부 흑색종 신규 진단 사례는 약 8,257건으로, 전체 암 관련 사망의 2.6%를 차지했습니다. 이 증가하는 유병률은 OTC 국소 의약품 치료제에 대한 수요 확대에 기여하고 있습니다.

OTC 국소 의약품 시장의 선도 기업들은 가려움증과 피부 자극을 빠르고 효과적으로 완화하는 국소 항히스타민제와 같은 혁신적인 솔루션의 개발을 우선으로 하고 있습니다. 피부에 직접 바르는 이러한 약물은 히스타민을 차단하여 발적, 가려움증, 알레르기 반응을 완화합니다. 예를 들어, 2025년 4월 영국 기반 헬스케어 기업인 Kingsway Pharma Limited는 스테로이드 무첨가 항히스타민 크림인 Pyribenzamine Over the Counter (PBZ OTC)를 출시했습니다. 이 제품은 2세 이상 성인 및 어린이의 경미한 피부 자극과 가려움증에 빠르고 정확한 완화를 제공하도록 설계되었습니다. 비지성이고 빠르게 흡수되는 포뮬러로 가정용 응급 키트에 실용적인 선택입니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 19 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별, 국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

HBR
영문 목차

영문목차

Over-the-counter (OTC) topical drugs are medications intended for direct application to the skin or mucous membranes and can be obtained without a prescription. These drugs are primarily used to address minor ailments such as skin irritations, pain, inflammation, infections, or itching. They are generally regarded as safe and effective for public use, offering an accessible and convenient option for managing everyday non-critical health issues.

Key categories of OTC topical drugs include analgesics, antibiotics, antifungals, antipruritics (anti-itch agents), astringents, and others. Analgesics, commonly referred to as pain relievers, are used to reduce pain without causing unconsciousness and function by interrupting pain signals or modifying how the brain interprets pain. These products are utilized across various areas such as pain management, skin treatment, and wound care. Distribution takes place through numerous channels, such as hospital pharmacies, retail pharmacies, online platforms, and drugstores, catering to a broad spectrum of end-users including adults, children, and the elderly.

The over-the-counter topical drugs market research report is one of a series of new reports from The Business Research Company that cover over-the-counter topical drugs market statistics, including the over-the-counter topical drugs industry's global market size, regional shares, competitors with the over-the-counter topical drugs market share, detailed over-the-counter topical drugs market segments, market trends and opportunities, and any further data you may need to thrive in the over-the-counter topical drugs market. This over-the-counter topical drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The over the counter (OTC) topical drugs market size has grown rapidly in recent years. It will grow from $57.58 billion in 2024 to $63.41 billion in 2025 at a compound annual growth rate (CAGR) of 10.1%. This expansion during the historic period has been supported by factors such as the increasing occurrence of skin-related conditions, a growing inclination among consumers for self-treatment, enhanced awareness regarding skincare, a rise in the aging population, and the broader availability of improved drug formulations.

The over the counter (OTC) topical drugs market size is expected to see strong growth in the next few years. It will grow to $92.25 billion in 2029 at a compound annual growth rate (CAGR) of 9.8%. Contributing to this projected growth are factors such as the expanding use of online shopping platforms, the growing incidence of minor wounds and infections, rising interest in herbal and plant-based topical remedies, a surge in demand for over-the-counter pain management solutions, and the increasing adoption of digital health technologies. Key trends anticipated in the forecast period include innovation in drug delivery technologies, application of AI in product development, tailored skincare solutions driven by technology, progress in dermatological science, and enhancements in product packaging and application methods.

The rising incidence of skin cancer is anticipated to drive the growth of the over-the-counter (OTC) topical drugs market. Skin cancer, characterized by the uncontrolled growth of abnormal skin cells, is typically caused by ultraviolet (UV) radiation from the sun or tanning beds. Excessive exposure to UV rays damages the DNA in skin cells, increasing the risk of developing skin cancer. OTC topical drugs play a supportive role in managing symptoms and skin irritation during treatment, offering accessible relief options that complement prescribed therapies. These products help soothe affected areas and promote skin recovery, thereby enhancing patient comfort. For example, according to Cancer Australia, an Australia-based government agency, approximately 8,257 new cases of melanoma of the skin were diagnosed in 2023, representing 2.6% of all cancer-related deaths. This growing prevalence is contributing to the expanding demand for OTC topical treatments.

Leading companies in the OTC topical drugs market are prioritizing the development of innovative solutions such as topical antihistamines to provide quick and effective relief from itching and skin irritation. These medications, applied directly to the skin, work by blocking histamine, thereby alleviating redness, itching, and allergic reactions. For instance, in April 2025, Kingsway Pharma Limited, a UK-based healthcare company, introduced Pyribenzamine Over the Counter (PBZ OTC), a steroid-free antihistamine cream containing tripelennamine HCl. The product is designed to deliver fast, targeted relief for minor skin irritations and itching in both adults and children aged two and older. Its non-greasy, fast-absorbing formula makes it a practical choice for household first-aid kits.

In June 2024, Aterian Investment Partners LP, a U.S.-based private equity firm, acquired Contract Pharmaceuticals Limited (CPL) for an undisclosed amount. This strategic move is intended to support CPL's next phase of growth by enhancing its capabilities through investments in personnel, technology, and operational processes. The goal is to deliver greater value to customers and strengthen CPL's leadership in the manufacturing of non-sterile liquid and topical OTC drug products. CPL is a Canada-based contract development and manufacturing organization specializing in the development and commercial production of OTC topical medications.

Major players in the over the counter (otc) topical drugs market are Pfizer Inc., The Procter And Gamble Company, Johnson And Johnson, Bayer AG, Sanofi S.A., Abbott Laboratories, Novartis AG, GSK plc, 3M Company, Sun Pharmaceutical Industries Ltd, Perrigo Company plc, Cipla Limited, Zydus Cadila Healthcare Limited, Glenmark Pharmaceuticals Limited, Mankind Pharma Limited, PL Developments Inc., Emami Limited, LNK International Inc., Reckitt Benckiser Group plc, Trillium Health Care Products Inc., Allegiant Health Corporation, Vivunt Pharma Pvt. Ltd.

North America was the largest region in the over the counter (OTC) topical drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in over the counter (OTC) topical drugs report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the over the counter (OTC) topical drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The over the counter (OTC) topical drugs market consists of sales of calamine lotion, topical antiseptics, antiviral creams, anti-itch creams, and wart removal products. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Over The Counter (OTC) Topical Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on over the counter (otc) topical drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for over the counter (otc) topical drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The over the counter (otc) topical drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Over The Counter (OTC) Topical Drugs Market Characteristics

3. Over The Counter (OTC) Topical Drugs Market Trends And Strategies

4. Over The Counter (OTC) Topical Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Over The Counter (OTC) Topical Drugs Growth Analysis And Strategic Analysis Framework

6. Over The Counter (OTC) Topical Drugs Market Segmentation

7. Over The Counter (OTC) Topical Drugs Market Regional And Country Analysis

8. Asia-Pacific Over The Counter (OTC) Topical Drugs Market

9. China Over The Counter (OTC) Topical Drugs Market

10. India Over The Counter (OTC) Topical Drugs Market

11. Japan Over The Counter (OTC) Topical Drugs Market

12. Australia Over The Counter (OTC) Topical Drugs Market

13. Indonesia Over The Counter (OTC) Topical Drugs Market

14. South Korea Over The Counter (OTC) Topical Drugs Market

15. Western Europe Over The Counter (OTC) Topical Drugs Market

16. UK Over The Counter (OTC) Topical Drugs Market

17. Germany Over The Counter (OTC) Topical Drugs Market

18. France Over The Counter (OTC) Topical Drugs Market

19. Italy Over The Counter (OTC) Topical Drugs Market

20. Spain Over The Counter (OTC) Topical Drugs Market

21. Eastern Europe Over The Counter (OTC) Topical Drugs Market

22. Russia Over The Counter (OTC) Topical Drugs Market

23. North America Over The Counter (OTC) Topical Drugs Market

24. USA Over The Counter (OTC) Topical Drugs Market

25. Canada Over The Counter (OTC) Topical Drugs Market

26. South America Over The Counter (OTC) Topical Drugs Market

27. Brazil Over The Counter (OTC) Topical Drugs Market

28. Middle East Over The Counter (OTC) Topical Drugs Market

29. Africa Over The Counter (OTC) Topical Drugs Market

30. Over The Counter (OTC) Topical Drugs Market Competitive Landscape And Company Profiles

31. Over The Counter (OTC) Topical Drugs Market Other Major And Innovative Companies

32. Global Over The Counter (OTC) Topical Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Over The Counter (OTC) Topical Drugs Market

34. Recent Developments In The Over The Counter (OTC) Topical Drugs Market

35. Over The Counter (OTC) Topical Drugs Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기